Amyloid, presenilins, and Alzheimer's disease.

Neuroscientist

Neuronal Member Trafficking Laboratory, Department of Human Genetics, Flanders Interuniversity Institute of Biotechnology (VIB04), Gasthuisberg, KULeuven, Herestraat 49, B-3000 Leuven, Belgium.

Published: April 2003

The regulated intramembrane proteolysis of the amyloid precursor protein (APP) that results in the generation of a toxic 40 to 42 amino acid fragment, Abeta, and a C-terminal intracellular fragment stands central in the pathogenesis of Alzheimer's disease. The fibrillar Abeta peptide is extracellularly deposited in plaques in the amygdala, the hippocampus, and the neocortex of affected individuals. The APP intracellular fragment binds to transcription factors and is translocated to the nucleus, where it influences transcription. Regulated intramembrane proteolysis of APP is dependent on the activity of a multimeric protein complex of which the essential components are presenilin, nicastrin, PEN-2, and APH-1. Further research into this emerging field of presenilin-dependent APP proteolysis within the plane of the membrane might reveal the necessity of an additional transport step-bringing substrate and enzyme together-before APP can actually be processed.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1073858403252227DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
8
regulated intramembrane
8
intramembrane proteolysis
8
intracellular fragment
8
app
5
amyloid presenilins
4
presenilins alzheimer's
4
disease regulated
4
proteolysis amyloid
4
amyloid precursor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!